Does prevention of vasospasm in subarachnoid hemorrhage improve clinical outcome? yes

Stroke

Volumn 44, Issue SUPPL. 1, 2013, Pages

  Macdonald, Robert Loch ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Angiographic vasospasm; Delayed cerebral ischemia; Subarachnoid hemorrhage

Indexed keywords

CLAZOSENTAN;

BRAIN VASOSPASM; CONFERENCE PAPER; DRUG EFFECT; HUMAN; HYPOTENSION; LUNG DISEASE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

ANGIOGRAPHIC VASOSPASM; DELAYED CEREBRAL ISCHEMIA; SUBARACHNOID HEMORRHAGE;

HUMANS; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

EID: 84880297333     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.112.679142     Document Type: Conference Paper

References (25)

1. Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S, et al; CONSCIOUS-1 Investigators. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke. 2008;39:3015-3021.
2. Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, et al. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol. 2011;10:618-625.
3. Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, et al. Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling. Stroke. 2012;43:1463-1469.
4. Millikan CH. Cerebral vasospasm and ruptured intracranial aneurysm. Arch Neurol. 1975;32:433-449.
5. Etminan N, Vergouwen MD, Ilodigwe D, Macdonald RL. Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Cereb Blood Flow Metab. 2011;31:1443-1451.
6. Sehba FA, Bederson JB. Mechanisms of acute brain injury after subarachnoid hemorrhage. Neurol Res. 2006;28:381-398.
7. Stein SC, Browne KD, Chen XH, Smith DH, Graham DI. Thromboembolism and delayed cerebral ischemia after subarachnoid hemorrhage: an autopsy study. Neurosurgery. 2006;59:781-787; discussion 787-788.
8. Dreier JP. The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat Med. 2011;17: 439-447.
9. McGirt MJ, Parra A, Sheng H, Higuchi Y, Oury TD, Laskowitz DT, et al. Attenuation of cerebral vasospasm after subarachnoid hemorrhage in mice overexpressing extracellular superoxide dismutase. Stroke. 2002;33:2317-2323.
10. Prunell GF, Svendgaard NA, Alkass K, Mathiesen T. Delayed cell death related to acute cerebral blood flow changes following subarachnoid hemorrhage in the rat brain. J Neurosurg. 2005;102:1046-1054.
11. Takata K, Sheng H, Borel CO, Laskowitz DT, Warner DS, Lombard FW. Long-term cognitive dysfunction following experimental subarachnoid hemorrhage: new perspectives. Exp Neurol. 2008;213:336-344.
12. Rosengart AJ, Schultheiss KE, Tolentino J, Macdonald RL. Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage. Stroke. 2007;38:2315-2321.
13. Jeon H, Ai J, Sabri M, Tariq A, Shang X, Chen G, et al. Neurological and neurobehavioral assessment of experimental subarachnoid hemorrhage. BMC Neurosci. 2009;10:103.
14. Weir B. The effect of clot removal on cerebral vasospasm. Neurosurg Clin N Am. 1990;1:377-385.
15. Mesis RG, Wang H, Lombard FW, Yates R, Vitek MP, Borel CO, et al. Dissociation between vasospasm and functional improvement in a murine model of subarachnoid hemorrhage. Neurosurg Focus. 2006;21:E4.
16. Tibbs R, Zubkov A, Aoki K, Meguro T, Badr A, Parent A, et al. Effects of mitogen-activated protein kinase inhibitors on cerebral vasospasm in a double-hemorrhage model in dogs. J Neurosurg. 2000;93:1041-1047.
17. Lovelock CE, Rinkel GJ, Rothwell PM. Time trends in outcome of subarachnoid hemorrhage: Population-based study and systematic review. Neurology. 2010;74:1494-1501.
18. Haley EC Jr., Kassell NF, Torner JC. A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg. 1993;78:537-547.
19. Kreiter KT, Mayer SA, Howard G, Knappertz V, Ilodigwe D, Sloan MA, et al. Sample size estimates for clinical trials of vasospasm in subarachnoid hemorrhage. Stroke. 2009;40:2362-2367.
20. Molyneux A, Kerr R, Stratton I, Sandercock P, Clarke M, Shrimpton J, et al International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet. 2002;360:1267-1274.
21. Dhar R, Scalfani MT, Zazulia AR, Videen TO, Derdeyn CP, Diringer MN. Comparison of induced hypertension, fluid bolus, and blood transfusion to augment cerebral oxygen delivery after subarachnoid hemorrhage. J Neurosurg. 2012;116:648-656.
22. Dorhout Mees SM, Kerr RS, Rinkel GJ, Algra A, Molyneux AJ. Occurrence and impact of delayed cerebral ischemia after coiling and after clipping in the International Subarachnoid Aneurysm Trial (ISAT). J Neurol. 2012;259:679-683.
23. Dumont AS, Crowley RW, Monteith SJ, Ilodigwe D, Kassell NF, Mayer S, et al. Endovascular treatment or neurosurgical clipping of ruptured intracranial aneurysms: effect on angiographic vasospasm, delayed ischemic neurological deficit, cerebral infarction, and clinical outcome. Stroke. 2010;41:2519-2524.
24. Liebeskind DS. Collateral circulation. Stroke. 2003;34:2279-2284.
25. Bassiouni H, Schulz R, Dörge H, Stolke D, Heusch G. The impact of subarachnoid hemorrhage on regional cerebral blood flow and largevessel diameter in the canine model of chronic vasospasm. J Stroke. Cerebrovasc Dis. 2007;16:45-51.